About FDA
Percent of advisory committee members participating in meetings in the month who were granted waivers
FY 2012 Target: Less than 11.5%
Dictionary: When FDA determines that an advisory committee member has a financial conflict of interest, the agency may grant a waiver that allows the member to participate in an advisory committee meeting if certain criteria and policies are met. In general, FDA may grant a waiver if the member's expertise is considered essential to the committee’s discussions and recommendations. FDA must also take into consideration a cap on the number of waivers that can be granted each year. FDA searches for experts who have the necessary expertise without conflicts of interest; yet, in some cases, many of the top authorities in specialized scientific fields may have a conflict of interest. When FDA grants a waiver, the financial interests associated with the waiver are posted on FDA’s website along with the reasons for granting the waiver.
Information is current as of December 31, 2012.
Fiscal Year - 2012
FY 2012 Target: Less than 11.5%
| Time | Target | Percent Granted Waivers |
|---|---|---|
| Oct 2011 | 11.5 | 0 |
| Nov 2011 | 11.5 | 0 |
| Dec 2011 | 11.5 | 0 |
| Jan 2012 | 11.5 | 0 |
| Feb 2012 | 11.5 | 0 |
| Mar 2012 | 11.5 | 7 |
| Apr 2012 | 11.5 | 0 |
| May 2012 | 11.5 | 2 |
| Jun 2012 | 11.5 | 1 |
| Jul 2012 | 11.5 | 0 |
| Aug 2012 | 11.5 | 0 |
| Sep 2012 | 11.5 | 0 |
FY 2012 Overall: 1%
Total number of advisory committee members participating in meetings in the month who were granted waivers
Fiscal Year - 2012
| Time | Target | Waivers Granted |
|---|---|---|
| Oct 2011 | N/A | 0 |
| Nov 2011 | N/A | 0 |
| Dec 2011 | N/A | 0 |
| Jan 2012 | N/A | 0 |
| Feb 2012 | N/A | 0 |
| Mar 2012 | N/A | 9 |
| Apr 2012 | N/A | 0 |
| May 2012 | N/A | 4 |
| Jun 2012 | N/A | 1 |
| Jul 2012 | N/A | 0 |
| Aug 2012 | N/A | 0 |
| Sep 2012 | N/A | 0 |
FY 2012 Total: 14
Total number of advisory committee members participating in meetings in the month
Fiscal Year - 2012
| Time | Target | Committee Members |
|---|---|---|
| Oct 2011 | N/A | 54 |
| Nov 2011 | N/A | 178 |
| Dec 2011 | N/A | 153 |
| Jan 2012 | N/A | 82 |
| Feb 2012 | N/A | 140 |
| Mar 2012 | N/A | 137 |
| Apr 2012 | N/A | 94 |
| May 2012 | N/A | 195 |
| Jun 2012 | N/A | 94 |
| Jul 2012 | N/A | 46 |
| Aug 2012 | N/A | 33 |
| Sep 2012 | N/A | 122 |
FY 2012 Total: 1,328
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.







